文献速递神经核医学

使用[123I]epidepride SPECT对纹状体及纹状体外D2/3受体进行体内绝对定量

In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT.
PubMed 文献 · EJNMMI Res · 2020-06-16

该研究在18只雄性大鼠中建立部分饱和协议,通过单次动态SPECT获得体内Scatchard图,分别估计纹状体及纹状体外D2/3受体的Bavail和appKd,并与多注射2T-5k模型比较。模拟显示3 μg/kg未标记epidepride可形成体内Scatchard图,部分饱和法估计的Bavail与多注射法高度相关(r=0.99)。慢性氟哌啶醇(1 mg/kg/天)使左侧尾壳核Bavail增加17.9%(p=0.07)、右侧增加13.8%(p=0.12)。

要点

  • 部分饱和协议可在单次动态SPECT中同时定量纹状体及纹状体外D2/3受体。
  • 模拟显示3 μg/kg未标记epidepride可形成体内Scatchard图。
  • 部分饱和法估计的Bavail与多注射2T-5k模型高度相关(r=0.99)。

核心结论

  • 部分饱和法可通过单次扫描稳健定量纹状体及纹状体外D2/3受体,可能应用于转化生物学研究和临床SPECT成像。

研究设计与样本

  • 研究使用18只雄性大鼠,采用多注射协议进行[123I]epidepride的全动力学建模(两组织室、5参数模型,2T-5k)以估计结合参数。
  • 通过多种模拟估计部分饱和协议的最佳条件,并在区域和体素水平应用该协议。
  • 将部分饱和研究结果与2T-5k模型结果进行比较。
  • 初步研究慢性皮下注射氟哌啶醇(1 mg/kg/天)对大鼠纹状体[123I]epidepride Bavail的影响。

主要发现

  • 模拟显示3 μg/kg未标记epidepride可形成体内Scatchard图。
  • 部分饱和研究在所有脑区稳健估计Bavail,与多注射研究对应值高度相关(r=0.99)。
  • 慢性氟哌啶醇治疗使左侧尾壳核Bavail增加17.9%(p=0.07),右侧尾壳核增加13.8%(p=0.12)。

临床怎么用

  • 作者认为该方法可能应用于转化生物学研究中的D2/3受体映射,并可能应用于临床SPECT成像。

局限性

  • 慢性氟哌啶醇对左侧尾壳核Bavail的增加17.9%未达统计学显著(p=0.07)。
  • 慢性氟哌啶醇对右侧尾壳核Bavail的增加13.8%未达统计学显著(p=0.12)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: [123I]epidepride is a high-affinity radiotracer used in single-photon emission computed tomography (SPECT) imaging of the D2/3 receptors. It binds with high affinity to striatal and extrastriatal receptors. Nevertheless, its slow kinetics in the striatum impedes quantification in this region. Thus, an approach that would allow a simultaneous quantification of both striatal and extrastriatal D2/3 receptors would be of interest for preclinical and clinical SPECT neuroimaging. We describe a partial saturation protocol that allows us to produce an in vivo Scatchard plot and thus estimate Bavail and appKd separately in both striatal and extrastriatal regions, through a single dynamic SPECT session. To validate this approach, a multi-injection protocol is used for the full kinetic modeling of [123I]epidepride using a two-tissue compartment, 5-parameter model (2T-5k). METHODS: Eighteen male rats were used. Binding parameters were estimated using the multi-injection protocol. Various simulations were performed to estimate the optimal conditions for the partial saturation protocol, which was applied at the region and voxel level. The results of the partial saturation study were compared to those obtained with the 2T-5k model. To illustrate the interest of the partial saturation approach, we performed a preliminary study of the effect of a chronic, subcutaneous administration of haloperidol (1 mg/kg/day), a D2 receptor antagonist, on the Bavail of [123I]epidepride in the rat striatum. RESULTS: A series of simulations demonstrated that a mass of 3 ug/kg of unlabeled epidepride allows the formation of an in vivo Scatchard plot. The partial saturation study led to robust estimations of Bavail in all brain regions that highly correlated (r = 0.99) with the corresponding values from the multi-injection study. A chronic haloperidol treatment resulted in a 17.9% increase in the Bavail values in the left Caudate Putamen nucleus (CP) (p = 0.07) and a 13.8% increase in the right CP (p = 0.12). CONCLUSION: A partial saturation method allowed the robust quantification of D2/3 receptors in striatal and extrastriatal D2/3 receptors with a single-scan approach. This approach may be applied in the mapping of the D2/3 receptor in translational biological studies and potentially, in clinical SPECT imaging.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Tsartsalis S, Tournier BB, Millet P, et al. In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT. EJNMMI Res. 2020. PMID: 32548681. doi:10.1186/s13550-020-00650-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。